002603 以岭药业
已收盘 01-09 15:00:00
资讯
新帖
简况
【重磅】以岭药业1类新药亮相！猛攻超800亿市场
证券之星 · 01-09 09:57
【重磅】以岭药业1类新药亮相！猛攻超800亿市场
以岭药业（002603）披露全资孙公司收到化学原料药上市申请批准通知书，1月7日股价上涨0.45%
证券之星 · 01-07 17:36
以岭药业（002603）披露全资孙公司收到化学原料药上市申请批准通知书，1月7日股价上涨0.45%
以岭药业入选“2025中国企业ESG百强”榜单
新浪财经 · 01-07 17:17
以岭药业入选“2025中国企业ESG百强”榜单
以岭药业(002603.SZ)：盐酸伐昔洛韦片取得药品注册证书
智通财经 · 01-07
以岭药业(002603.SZ)：盐酸伐昔洛韦片取得药品注册证书
以岭药业创新药益肾养心安神片被北京晚报评为家庭常备安神助眠用药
证券之星 · 01-05
以岭药业创新药益肾养心安神片被北京晚报评为家庭常备安神助眠用药
以岭药业以创新与社会责任诠释领军担当荣获“年度医药行业领军企业”
证券之星 · 01-04
以岭药业以创新与社会责任诠释领军担当荣获“年度医药行业领军企业”
以岭药业斩获全国首个酸枣仁GAP基地
证券之星 · 2025-12-31
以岭药业斩获全国首个酸枣仁GAP基地
流感疫情持续，防控系统工程再受考验
证券之星 · 2025-12-31
流感疫情持续，防控系统工程再受考验
以岭药业获第十四届金融界“金智奖”杰出投资者关系（IR）团队奖
证券之星 · 2025-12-27
以岭药业获第十四届金融界“金智奖”杰出投资者关系（IR）团队奖
以岭药业获评“2025年度医药行业AI赋能标杆案例”奖
证券之星 · 2025-12-23
以岭药业获评“2025年度医药行业AI赋能标杆案例”奖
中药材产业兴农书写责任答卷 以岭药业获评“2025企业社会责任公益榜样”
证券之星 · 2025-12-12
中药材产业兴农书写责任答卷 以岭药业获评“2025企业社会责任公益榜样”
以岭药业（002603）披露召开2025年第二次临时股东大会通知，12月08日股价下跌1.32%
证券之星 · 2025-12-08
以岭药业（002603）披露召开2025年第二次临时股东大会通知，12月08日股价下跌1.32%
6个中成药跻身国家医保目录新增名单，康缘、以岭、三九、方盛各有产品入选
智通财经网 · 2025-12-08
6个中成药跻身国家医保目录新增名单，康缘、以岭、三九、方盛各有产品入选
以岭药业：子公司独家产品芪防鼻通片首次纳入国家医保目录
证券日报 · 2025-12-07
以岭药业：子公司独家产品芪防鼻通片首次纳入国家医保目录
以岭药业拟将化学制剂国际产业化项目节余募集资金1.61亿元永久补流
中金财经 · 2025-12-06
以岭药业拟将化学制剂国际产业化项目节余募集资金1.61亿元永久补流
以岭药业拟修订《公司章程》 删除监事会并强化董事会职能
中金财经 · 2025-12-06
以岭药业拟修订《公司章程》 删除监事会并强化董事会职能
以岭药业荣膺“阳光”年度杰出药物研发创新企业
证券之星 · 2025-12-01
以岭药业荣膺“阳光”年度杰出药物研发创新企业
以岭药业（002603）披露全资子公司药品注册申请进展公告，11月27日股价下跌0.21%
证券之星 · 2025-11-27
以岭药业（002603）披露全资子公司药品注册申请进展公告，11月27日股价下跌0.21%
11月25日以岭药业涨5.91%，长信金利趋势混合A基金重仓该股
证券之星 · 2025-11-25
11月25日以岭药业涨5.91%，长信金利趋势混合A基金重仓该股
“冀”往开来铸春秋 | 以岭药业：以络病理论为根 铸中医药创新之魂
证券之星 · 2025-11-25
“冀”往开来铸春秋 | 以岭药业：以络病理论为根 铸中医药创新之魂
加载更多
公司概况
公司名称：
石家庄以岭药业股份有限公司
所属行业：
医药制造业
上市日期：
2011-07-28
主营业务：
石家庄以岭药业股份有限公司的主营业务是专利创新中药的研发、生产和销售。公司的主要产品是通心络胶囊、参松养心胶囊和芪苈强心胶囊。公司先后多次承担国家及省部级科研计划项目，荣获国家科技进步一等奖1项、国家科技进步二等奖4项、国家技术发明二等奖1项及省部级科技奖励20余项。
发行价格：
34.56
{"stockData":{"symbol":"002603","market":"SZ","secType":"STK","nameCN":"以岭药业","latestPrice":17.91,"timestamp":1767942225000,"preClose":17.72,"halted":0,"volume":22215566,"delay":0,"changeRate":0.0107,"floatShares":1377000000,"shares":1671000000,"eps":-0.167,"marketStatus":"已收盘","change":0.19,"latestTime":"01-09 15:00:00","open":17.72,"high":17.92,"low":17.6,"amount":394000000,"amplitude":0.0181,"askPrice":17.92,"askSize":711,"bidPrice":17.91,"bidSize":1656,"shortable":0,"etf":0,"ttmEps":-0.167,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768181400000},"marketStatusCode":5,"adr":0,"adjPreClose":17.72,"symbolType":"stock","openAndCloseTimeList":[[1767922200000,1767929400000],[1767934800000,1767942000000]],"highLimit":19.49,"lowLimit":15.95,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1670705376,"isCdr":false,"pbRate":2.77,"roa":"--","roe":"9.34%","epsLYR":-0.4337,"committee":0.361969,"marketValue":29922000000,"turnoverRate":0.0161,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-01-12。","floatMarketCap":24659000000},"requestUrl":"/m/hq/s/002603","defaultTab":"news","newsList":[{"id":"2602310178","title":"【重磅】以岭药业1类新药亮相！猛攻超800亿市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2602310178","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602310178?lang=zh_cn&edition=full","pubTime":"2026-01-09 09:57","pubTimestamp":1767923833,"startTime":"0","endTime":"0","summary":"今日，以岭药业的中药1.1类新药芪龙定喘片提交IND获受理。据悉，该药拟用于慢性阻塞性肺疾病稳定期心肺气虚、痰瘀阻滞证。芪龙定喘片是以岭药业2026年首款申报IND的创新药。米内网数据显示，2023-2024年中国三大终端六大市场呼吸系统疾病中成药销售额均超过800亿元，2025年前三季度超过500亿元。此外，化药1类新药G201-Na胶囊申报IND且获批临床，目前已步入II期临床，可在辅助生殖技术中，用于控制性超促排卵治疗的患者，防止提前排卵。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026010900009615.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0097","002603","BK0042","BK0046"],"gpt_icon":0},{"id":"2601760088","title":"以岭药业（002603）披露全资孙公司收到化学原料药上市申请批准通知书，1月7日股价上涨0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601760088","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601760088?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:36","pubTimestamp":1767778594,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘，以岭药业报收于17.71元，较前一交易日上涨0.45%，最新总市值为295.88亿元。近日，石家庄以岭药业股份有限公司全资孙公司万洋衡水制药有限公司收到国家药品监督管理局下发的化学原料药上市申请批准通知书，其提交的达格列净化学原料药上市申请已获批准。达格列净为SGLT-2抑制剂，用于治疗2型糖尿病，具有肾脏保护和心血管获益优势。该原料药已纳入第十一批国家集采目录，降价幅度超90%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700027317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0046","BK0042","BK0097","002603","BK0239"],"gpt_icon":0},{"id":"2601768608","title":"以岭药业入选“2025中国企业ESG百强”榜单","url":"https://stock-news.laohu8.com/highlight/detail?id=2601768608","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601768608?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:17","pubTimestamp":1767777420,"startTime":"0","endTime":"0","summary":" 近日，新浪财经重磅发布“2025中国企业ESG百强”榜单，凭借在环境、社会、治理领域的系统性卓越实践，以岭药业成功上榜。 历经30余年稳健发展，以岭药业构建起“理论—临床—新药—产业—教学”五位一体的的独特运营模式，为企业ESG实践筑牢坚实根基。评级体系基于企业可持续发展报告及第三方数据等，纳入150余项ESG指标，得到企业ESG综合评级得分。排名位列前100的企业入选“上市公司年度ESG百强榜”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-07/doc-inhfnqzp4656836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0188","BK0046","BK0239","BK0042","ESG","BK0097","002603","159717"],"gpt_icon":0},{"id":"2601878784","title":"以岭药业(002603.SZ)：盐酸伐昔洛韦片取得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2601878784","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601878784?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:24","pubTimestamp":1767774250,"startTime":"0","endTime":"0","summary":"智通财经APP讯，以岭药业(002603.SZ)公告，公司的全资子公司以岭万洲国际制药有限公司(简称“以岭万洲”)向国家药品监督管理局药品审评中心申报的盐酸伐昔洛韦片的上市许可申请，获得国家药品监督管理局的批准，取得药品注册证书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389808.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"以岭药业(002603.SZ)：盐酸伐昔洛韦片取得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0042","BK0097","BK0239","BK0046","002603","BK0188"],"gpt_icon":0},{"id":"2601075719","title":"以岭药业创新药益肾养心安神片被北京晚报评为家庭常备安神助眠用药","url":"https://stock-news.laohu8.com/highlight/detail?id=2601075719","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601075719?lang=zh_cn&edition=full","pubTime":"2026-01-05 09:46","pubTimestamp":1767577599,"startTime":"0","endTime":"0","summary":"12月31日，由《北京晚报》主办的“2025年度健康行业卓越品牌暨家庭常备药品/器械推选活动”系列榜单发布，以岭药业创新专利药物益肾养心安神片获评“2025北京晚报读者推荐家庭常备安神助眠用药”。据了解，《北京晚报》已连续十四年举办家庭常备药盘点活动。2025家庭常备药系列活动自11月启动以来，众多热心读者踊跃参与并分享意见建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026010500005007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002603","BK1161","BK0046","BK0042","BK0188","159992","BK1574","06978","BK0097","BK0239"],"gpt_icon":0},{"id":"2600704310","title":"以岭药业以创新与社会责任诠释领军担当荣获“年度医药行业领军企业”","url":"https://stock-news.laohu8.com/highlight/detail?id=2600704310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600704310?lang=zh_cn&edition=full","pubTime":"2026-01-04 11:04","pubTimestamp":1767495840,"startTime":"0","endTime":"0","summary":"在财经网2025年度新消费·新经济评选中，以岭药业荣获“年度医药行业领军企业”称号。作为中药现代化领军企业，以岭药业承担着一项特殊的时代责任：推动中医药突破文化隔阂，以国际公认的科学语言走向世界。这是对学科发展的责任，是对行业信心的提振，更是对中国智慧贡献全球健康事业的积极推动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026010400000375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002603","BK0046","BK0239","161912","BK0097","BK0042","BK0188"],"gpt_icon":0},{"id":"2595778461","title":"以岭药业斩获全国首个酸枣仁GAP基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2595778461","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595778461?lang=zh_cn&edition=full","pubTime":"2025-12-31 18:05","pubTimestamp":1767175521,"startTime":"0","endTime":"0","summary":"12月30日，河北省药品监督管理局发布《河北省药品监督管理局中药材GAP延伸检查结果公告》，以岭药业酸枣仁种植基地通过河北省药监局组织的GAP延伸检查，综合评定符合要求。这是全国第一个通过GAP延伸检查的酸枣仁基地。以岭药业建设酸枣仁规范化种植基地4760亩，野生抚育基地3200.49亩，基地位于河北省邢台市内丘县南赛乡。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025123100033663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","002603","BK0188","BK0042","BK0097"],"gpt_icon":0},{"id":"2595127727","title":"流感疫情持续，防控系统工程再受考验","url":"https://stock-news.laohu8.com/highlight/detail?id=2595127727","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595127727?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:18","pubTimestamp":1767172695,"startTime":"0","endTime":"0","summary":"2025年末，全国流感疫情持续处于高流行水平。产业链协同响应，构建多层次供应保障流感防控是一项系统工程，需要疫苗预防、快速诊断、药物治疗等多个环节的有效衔接。本轮疫情中，上市药企正通过全产业链布局，搭建从源头预防到终端治疗的健康保障网络。中成药在本轮疫情中表现活跃。公司表示，金振口服液四季度市场需求回暖，正加紧排产满足市场需要。随着该产品儿童流感新适应症的获批，其在儿科领域的应用场景进一步拓宽。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025123100030908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300244","002393","BK0197","000623","BK0077","BK0042","BK0046","002317","BK0188","BK0239","600557","BK0028","BK0012","BK0096","BK0185","BK0250","BK0187","BK0236","BK0060","BK0183","BK0070","002603","BK0097","603858","002728","600566","688276","BK0074","000756","BK0201","BK0196","BK0086","BK0284","BK0114","BK0146","BK0186","000999","300937","600079","301207","603882","BK0010","BK0175","SG9999001069.SGD","BK0164"],"gpt_icon":0},{"id":"2594111822","title":"以岭药业获第十四届金融界“金智奖”杰出投资者关系（IR）团队奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2594111822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594111822?lang=zh_cn&edition=full","pubTime":"2025-12-27 10:00","pubTimestamp":1766800813,"startTime":"0","endTime":"0","summary":"作为大会备受关注的重要成果，第十四届“金智奖”年度评选结果正式揭晓，以岭药业荣获“杰出投资者关系团队奖”。从公开信息来看，以岭药业IR团队的相关实践与上述评选标准高度契合。以岭药业此次获奖，被视为资本市场对其投资者关系管理专业性、合规性及有效性的认可，也为中药创新领域上市公司的投资者关系管理实践提供了参考样本。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025122700002984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0097","BK0042","002603","BK0188"],"gpt_icon":0},{"id":"2593346319","title":"以岭药业获评“2025年度医药行业AI赋能标杆案例”奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2593346319","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593346319?lang=zh_cn&edition=full","pubTime":"2025-12-23 11:35","pubTimestamp":1766460948,"startTime":"0","endTime":"0","summary":"12月18日，第六届中国医药数智峰会颁奖典礼在北京举行，以岭药业凭借“AI驱动医药营销全域智能化的规模化实践”，荣获“2025年度医药行业AI赋能标杆案例”奖项。同时，智能数智化总监孟得力荣获“医药行业AI战略领航者”。本次评选经过严格的多轮评审，最终筛选出在医药数智化领域具有标杆意义的优秀案例，旨在推动AI从技术工具升级为医药价值链的神经中枢，助力医药行业高质量发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.stockstar.com/SS2025122300014799.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","002603","BK0042","BK0097","BK0188","BK0239"],"gpt_icon":0},{"id":"2590557595","title":"中药材产业兴农书写责任答卷 以岭药业获评“2025企业社会责任公益榜样”","url":"https://stock-news.laohu8.com/highlight/detail?id=2590557595","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590557595?lang=zh_cn&edition=full","pubTime":"2025-12-12 15:33","pubTimestamp":1765524796,"startTime":"0","endTime":"0","summary":"12月9日，2025(第九届)企业社会责任活动在深圳举行，现场发布了深蓝媒体智库企业社会责任优秀案例榜单。以岭药业凭借在乡村振兴与生态保护领域的突出实践，获评“2025年度企业社会责任公益榜样”。作为中医药行业标杆，以岭药业始终将社会责任融入发展战略，构建起特色ESG实践体系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025121200018577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","161912","BK0042","BK0097","002603","BK0188","BK0046"],"gpt_icon":0},{"id":"2589336793","title":"以岭药业（002603）披露召开2025年第二次临时股东大会通知，12月08日股价下跌1.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589336793","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589336793?lang=zh_cn&edition=full","pubTime":"2025-12-08 17:43","pubTimestamp":1765186986,"startTime":"0","endTime":"0","summary":"截至2025年12月8日收盘，以岭药业报收于17.95元，较前一交易日下跌1.32%，最新总市值为299.89亿元。公司近日发布公告，宣布将于2025年12月22日召开2025年第二次临时股东大会，会议由董事会召集，采用现场表决与网络投票相结合的方式。其中，修改《公司章程》为特别决议事项，需经出席股东大会的股东所持表决权的2/3以上通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800021671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0097","002603","BK0042","BK0188"],"gpt_icon":0},{"id":"2589803385","title":"6个中成药跻身国家医保目录新增名单，康缘、以岭、三九、方盛各有产品入选","url":"https://stock-news.laohu8.com/highlight/detail?id=2589803385","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589803385?lang=zh_cn&edition=full","pubTime":"2025-12-08 11:31","pubTimestamp":1765164685,"startTime":"0","endTime":"0","summary":"根据国家医保局披露的名单，此次新增的6个中成药品种分别为：温阳解毒颗粒、参郁宁神片、养血祛风止痛颗粒、益气清肺颗粒、玉女煎颗粒、芪防鼻通片，其中包括3个1.1类新药，3个3类新药。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20251208/20251208113159_33210.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251208/20251208113159_33210.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"6个中成药跻身国家医保目录新增名单，康缘、以岭、三九、方盛各有产品入选","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0196","603998","BK0185","BK0046","000999","BK0175","BK0183","002603","BK0012","BK0097","BK0028","BK0042","600557","BK0239","BK0188","BK0010","BK0060"],"gpt_icon":0},{"id":"2589870690","title":"以岭药业：子公司独家产品芪防鼻通片首次纳入国家医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589870690","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589870690?lang=zh_cn&edition=full","pubTime":"2025-12-07 20:36","pubTimestamp":1765110960,"startTime":"0","endTime":"0","summary":"证券日报网讯 12月7日晚间，以岭药业发布公告称，公司全资子公司北京以岭药业有限公司独家产品芪防鼻通片通过了医保谈判，首次被纳入《国家基本医疗保险、生育保险和工伤保险药品目录（2025年）》。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-07/doc-infzyswc3253779.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-07/doc-infzyswc3253779.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","002603","BK0046","BK0188","BK0042","BK0097"],"gpt_icon":0},{"id":"2589633823","title":"以岭药业拟将化学制剂国际产业化项目节余募集资金1.61亿元永久补流","url":"https://stock-news.laohu8.com/highlight/detail?id=2589633823","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589633823?lang=zh_cn&edition=full","pubTime":"2025-12-06 19:01","pubTimestamp":1765018872,"startTime":"0","endTime":"0","summary":"中访网数据 石家庄以岭药业股份有限公司于2025年12月5日召开董事会及监事会会议，审议通过了关于公司2017年非公开发行股票募集资金投资项目结项并将节余募集资金永久补充流动资金的议案。本次拟结项的项目为“化学制剂国际产业化项目”。截至2025年11月30日，该项目承诺投入募集资金总额为54,513.40万元，已累计投入38,411.41万元，节余募集资金16,101.99万元。公司计划将上述节余资金永久补充流动资金，用于日常生产经营。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251206/31848935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","002603","BK0188","BK0097","BK0042","BK0046"],"gpt_icon":0},{"id":"2589840483","title":"以岭药业拟修订《公司章程》 删除监事会并强化董事会职能","url":"https://stock-news.laohu8.com/highlight/detail?id=2589840483","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589840483?lang=zh_cn&edition=full","pubTime":"2025-12-06 16:36","pubTimestamp":1765010162,"startTime":"0","endTime":"0","summary":"中访网数据 石家庄以岭药业股份有限公司于2025年12月5日召开董事会，审议通过了关于修改《公司章程》的议案。本次修订旨在适应新《公司法》等法规要求，并对公司治理结构进行重大调整。该议案尚需提交公司股东大会审议批准后方可生效。此次章程修订标志着以岭药业公司治理模式向董事会中心主义转型，旨在进一步优化决策与监督机制。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251206/31848908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0042","BK0239","BK0188","BK0046","002603","BK0097"],"gpt_icon":0},{"id":"2588103317","title":"以岭药业荣膺“阳光”年度杰出药物研发创新企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2588103317","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588103317?lang=zh_cn&edition=full","pubTime":"2025-12-01 10:59","pubTimestamp":1764557941,"startTime":"0","endTime":"0","summary":"11月26日，2025年第九届21世纪大健康产业竞争力研究“阳光”案例榜单正式揭晓。以岭药业凭借其持续的创新研发实力和丰硕的科技成果荣膺创新研发卓越类“年度杰出药物研发创新企业”。作为积极响应国家大健康战略的践行者，以岭药业始终将研发创新置于企业发展的核心位置，长期保持高强度的研发投入。数据显示，2025年前三季度，以岭药业研发费用达5.44亿元，占营收比例达9.27%；2019至2024年间，累计研发投入已超50亿元，持续领跑行业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025120100006720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0097","BK0188","BK0042","BK0239","002603"],"gpt_icon":0},{"id":"2586223750","title":"以岭药业（002603）披露全资子公司药品注册申请进展公告，11月27日股价下跌0.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586223750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586223750?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:02","pubTimestamp":1764252146,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘，以岭药业报收于19.13元，较前一交易日下跌0.21%，最新总市值为319.61亿元。该股当日开盘19.25元，最高19.37元，最低18.97元，成交额达7.07亿元，换手率为2.68%。公司近日发布公告称，其全资子公司北京以岭药业有限公司收到国家药品监督管理局通知，同意撤回‘柴黄利胆胶囊’药品注册申请。2024年6月，该注册申请曾获国家药监局受理。本次撤回预计不会对公司当期及未来生产经营与业绩产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002603","BK0046","BK0042","BK0239","BK0188","BK0097"],"gpt_icon":0},{"id":"2586447529","title":"11月25日以岭药业涨5.91%，长信金利趋势混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2586447529","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586447529?lang=zh_cn&edition=full","pubTime":"2025-11-25 15:36","pubTimestamp":1764056180,"startTime":"0","endTime":"0","summary":"证券之星消息，11月25日以岭药业涨5.91%，收盘报19.16元，换手率4.46%，成交量61.39万手，成交额11.58亿元。重仓以岭药业的公募基金请见下表：该股最近90天内共有10家机构给出评级，买入评级8家，增持评级2家；过去90天内机构目标均价为20.57。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共8家，其中持有数量最多的公募基金为长信基金的长信金利趋势混合A。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500017435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002603","BK0097","BK0188","BK0046","BK0042"],"gpt_icon":0},{"id":"2586414519","title":"“冀”往开来铸春秋 | 以岭药业：以络病理论为根 铸中医药创新之魂","url":"https://stock-news.laohu8.com/highlight/detail?id=2586414519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586414519?lang=zh_cn&edition=full","pubTime":"2025-11-25 08:57","pubTimestamp":1764032276,"startTime":"0","endTime":"0","summary":"以岭药业董事、董事会秘书吴瑞表示。以岭药业首次系统构建了“络病理论”体系，出版了《络病学》《脉络论》《气络论》等著作，被誉为“中医络病研究史上的第四个里程碑”。截至目前，以岭药业成功研发17个专利中药，覆盖心脑血管、呼吸、糖尿病、肿瘤、神经、泌尿、妇科、抗衰老等八大疾病领域，其中11个品种进入国家医保目录、5个进入国家基药目录，成为中医药创新转化的典范。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2025112500004704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","BK0239","BK0188","002603","BK0097"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768035600337,"stockEarnings":[{"period":"1week","weight":0.0492},{"period":"1month","weight":0.017},{"period":"3month","weight":0.1235},{"period":"6month","weight":0.2214},{"period":"1year","weight":0.1319},{"period":"ytd","weight":0.0492}],"compareEarnings":[{"period":"1week","weight":0.0382},{"period":"1month","weight":0.0564},{"period":"3month","weight":0.0573},{"period":"6month","weight":0.1739},{"period":"1year","weight":0.2831},{"period":"ytd","weight":0.0382}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"石家庄以岭药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"152746人(较上一季度减少10.22%)","perCapita":"9013股","listingDate":"2011-07-28","address":"河北省石家庄市裕华区高新技术产业开发区天山大街238号","registeredCapital":"167070万元","survey":" 石家庄以岭药业股份有限公司的主营业务是专利创新中药的研发、生产和销售。公司的主要产品是通心络胶囊、参松养心胶囊和芪苈强心胶囊。公司先后多次承担国家及省部级科研计划项目，荣获国家科技进步一等奖1项、国家科技进步二等奖4项、国家技术发明二等奖1项及省部级科技奖励20余项。","listedPrice":34.56},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"以岭药业(002603)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供以岭药业(002603)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"以岭药业,002603,以岭药业股票,以岭药业股票老虎,以岭药业股票老虎国际,以岭药业行情,以岭药业股票行情,以岭药业股价,以岭药业股市,以岭药业股票价格,以岭药业股票交易,以岭药业股票购买,以岭药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"以岭药业(002603)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供以岭药业(002603)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}